Trial Profile
AN OPEN-LABEL, PHASE 3 STUDY OF THE CONTRACEPTIVE EFFICACY AND SAFETY OF AGILE TRANSDERMAL CONTRACEPTIVE DELIVERY SYSTEM (TCDS) IN SEXUALLY ACTIVE WOMEN REQUESTING CONTRACEPTION.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Nov 2012
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/levonorgestrel (Primary)
- Indications Pregnancy
- Focus Registrational; Therapeutic Use
- 04 Jan 2012 Status changed from recruiting to completed as reported by Agile Therapeutics
- 19 Jul 2011 New trial record